SEC Form 4 · accession 0001645627-17-000108
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 15, 2017
Accepted (ET)
Aug 17, 2017 · 3:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2017 | P | 3,000 | $0.0263 | A | 22,403,889 | D | |
| Common Stock | Aug 15, 2017 | P | 5,000 | $0.026 | A | 22,408,889 | D | |
| Common Stock | Aug 15, 2017 | P | 3,000 | $0.026 | A | 22,411,889 | D | |
| Common Stock | Aug 15, 2017 | P | 2,000 | $0.0268 | A | 22,413,889 | D | |
| Common Stock | Aug 15, 2017 | P | 3,000 | $0.0269 | A | 22,416,889 | D | |
| Common Stock | Aug 15, 2017 | P | 2,000 | $0.0268 | A | 22,418,889 | D | |
| Common Stock | Aug 15, 2017 | P | 5,000 | $0.0268 | A | 22,423,889 | D | |
| Common Stock | Aug 16, 2017 | P | 2,000 | $0.027 | A | 22,425,889 | D | |
| Common Stock | Aug 16, 2017 | P | 3,000 | $0.0272 | A | 22,428,889 | D | |
| Common Stock | Aug 16, 2017 | P | 5,000 | $0.0272 | A | 22,433,889 | D | |
| Common Stock | Aug 16, 2017 | P | 3,000 | $0.0272 | A | 22,436,889 | D | |
| Common Stock | Aug 16, 2017 | P | 5,000 | $0.0272 | A | 22,441,889 | D | |
| Common Stock | Aug 16, 2017 | P | 2,000 | $0.0291 | A | 22,443,889 | D | |
| Common Stock | Aug 16, 2017 | P | 2,000 | $0.0272 | A | 22,445,889 | D | |
| Common Stock | Aug 16, 2017 | P | 2,000 | $0.0272 | A | 22,447,889 | D |
Table II — derivative securities
No Table II lines on this filing.